Maryland Regional Cancer Center

Maryland Regional Cancer Center is a healthcare provider specializing in radiation oncology, with primary facilities located in Salisbury and Berlin, Maryland. The center offers a comprehensive suite of radiation therapy services, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and brachytherapy. It focuses on treating a wide range of malignancies, such as prostate, breast, lung, and skin cancers, using advanced linear accelerator technology. Historically, the center operated as part of the 21st Century Oncology network before being acquired by GenesisCare in 2020. Following GenesisCare's financial restructuring and exit from the United States market in 2023, the center's operations were acquired by TidalHealth. The facility is now integrated into the TidalHealth Richard A. Henson Cancer Institute, continuing to serve the Eastern Shore community.